SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-16-018987
Filing Date
2016-05-10
Accepted
2016-05-10 16:52:01
Documents
62
Period of Report
2016-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q vktx-10q_20160331.htm 10-Q 1663916
2 EX-31.1 vktx-ex311_8.htm EX-31.1 19063
3 EX-31.2 vktx-ex312_6.htm EX-31.2 19134
4 EX-32.1 vktx-ex321_9.htm EX-32.1 12791
  Complete submission text file 0001564590-16-018987.txt   7099238

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT vktx-20160331.xml EX-101.INS 1670496
6 XBRL TAXONOMY EXTENSION SCHEMA vktx-20160331.xsd EX-101.SCH 52800
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE vktx-20160331_cal.xml EX-101.CAL 36902
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE vktx-20160331_def.xml EX-101.DEF 192092
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE vktx-20160331_lab.xml EX-101.LAB 393008
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vktx-20160331_pre.xml EX-101.PRE 321066
Mailing Address 12340 EL CAMINO REAL, SUITE 250 SAN DIEGO CA 92130
Business Address 12340 EL CAMINO REAL, SUITE 250 SAN DIEGO CA 92130 858-704-4660
Viking Therapeutics, Inc. (Filer) CIK: 0001607678 (see all company filings)

IRS No.: 461073877 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37355 | Film No.: 161636486
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences